Monthly Archives: July 2021

Jab if you do … Jab if you don’t

July 3, 2021 By in Catherine Austin Fitts, David Knight, The Speck, Vernon Coleman

Those injected, thought they could travel

If you’re a leader, business owner or entrepreneur, dealing with idiots is probably the most frustrating part of running a business.

The leader has an absolutely thankless job most of the time.

However, there are times where being someone that can think, act, and be resistant to the criticisms of the crowd (‘double-jabbed zombies’ as Dr. Vernon Coleman calls them), pays off in spades.

At least we don’t have to put up with being played as we see here.

As we move forward to fall and winter, we’ll find out just how important resisting the peer pressure of the (double-jabbed) crowd may be.

On the practical side, David Knight interviews Catherine Austin Fitts on steps that can be implemented for personal financial and legal protection.

She touches on a subject that’s been covered several times on this site; that is, killing-off your customers is not good for future business.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Downside Leaders: Gold, Biotech

July 2, 2021 By in Biotech, BIS, GDX, GOLD, Gold & Silver, Gold Miners, Holiday Turns, IBB, LABD, Prechter, SPBIO

11:39 a.m., EST

Biotech SPBIO, Down Over 21%

Miners GDX, Down Over 25%

As of about 10:50 a.m., EST, this is where we are from a sector standpoint.

The major indices are masking the potential the next leg down, has already started.

Yesterday’s update posted the link for ‘Holiday Turns’.

It’s a list of empirical observation that market tops (reversals) tend to occur during holiday weeks.

The weekly chart of biotech SPBIO (which has been inverted), shows a Fibonacci 21-weeks, from the all time high (low on the chart) to this week’s pivot:

Not only is SPBIO adhering to Fibonacci time prints on the weekly, it’s doing it on the daily as well.

It was a Fibonacci 34 days to complete the 38%, retrace.

It was a Fibonacci 5 days to complete the most recent reversal and test; culminating early this session.

As stated many times, the bottom may fall out of biotech.

Someone or something in the criminal cabal is going to let loose; fully exposing the real intent of the entire operation.

Recall Prechter’s admonition; ‘price leads the news’

If SPBIO reverses at week 21, with a decisive move lower, it may not be long before news precipitates out into the mainstream.

We’re now two-hours into the trading day.

It’s typical for SPBIO, to begin its erosion (discussed here). Let’s see if it can retrace the sharp down move from the early session.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

SOXX: Signs of a Top

July 1, 2021 By in AA, David Weis, Holiday Turns, SOXS, SOXX, UAL 2 Comments

10:56 a.m., EST

Semiconductor SOXX, at Danger Point

‘Spring-to-Up thrust’ is a common price action phenomenon.

Credit goes to the late David Weis for noting this behavior in one of his daily market updates from years past.

Now, we see it in action with SOXX.

As with airlines, semiconductors are highly susceptible to economic changes. Both operate on thin margins and have high capital costs.

Airlines (at least UAL and AA) have never recovered to new all-time highs. Maybe the semis went higher because of all the contract tracing that’s being projected.

However, noted in yesterday’s update, there’s a chance there won’t be much to ‘trace’; we’ll find out very soon.

SOXX is at the danger point; risk of a short position (not advice not a recommendation) is at minimum.

As an extra reminder, we’ll add a frequently discussed theme for market tops: ‘Holiday Turns‘

Emperical data shows that markets tend to reverse before, during, or just after a holiday week.

This week could be one of those.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.